關鍵數據
3.470今開
3.545最高
33.25K成交量
1.85本益比TTM
2.11本益比動
0.600股利TTM
0.06%換手率
3.435昨收
3.470最低
91.18K成交額
2.20本益比靜
-0.34市淨率
16.95%股息率 TTM
10.41%ROA
15.55052週最高
0.57量比
95.40M淨利潤
59.21M總股本
1.9092每股盈餘TTM
1.09Beta
--ROE
8.47052週最低
2.18%振幅
56.45%毛利率
209.62M總市值
-0.48回報/風險
3.29%風險率
操作建議
Embecta Corp當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名56/199位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為10.00。中期看,股價處於下降通道。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
Embecta Corp新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Zimmer Biomet Holdings Inc
ZBH
31
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Embecta Corp簡介
Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
公司代碼EMBC
公司Embecta Corp
CEOKurdikar (Devdatt)
網址https://www.embecta.com/
公司股東
常見問題
Embecta Corp(EMBC)的當前股價是多少?
Embecta Corp(EMBC)的當前股價是 3.43。
Embecta Corp股票的52週最高點是多少?
Embecta Corp股票的52週最高點是15.55。
Embecta Corp股票的52週最低點是多少?
Embecta Corp股票的52週最低點是8.47。
現在Embecta Corp(EMBC)的股票是買入、持有還是賣出?
根據分析師評級,Embecta Corp(EMBC)的總體評級為signal_hold,目標價格為10.00。
Embecta Corp(EMBC)股票的每股收益(EPS TTM)是多少
Embecta Corp(EMBC)股票的每股收益(EPS TTM)是1.64。